|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Gimeracil>> Market Analysis Reports |
Market Analysis Reports of Gimeracil |
|
Geneticin Disulfate (CAS 103766-25-2) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Gimeracil Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of Gimeracil (CAS 103766-25-2) December 2024 Investigation Report on China Tegafur, Gimeracil and Oteracil (Tegafur/gimeracil/oteracil) Market, 2010-2019 ... cancer patients use tegafur, gimeracil and oteracil in chemotherapy, CR + PR reaching ... 6%. According to CRI’s statistics, tegafur, gimeracil and oteracil develops fast after ... market major manufacturers of tegafur, gimeracil and oteracil in China share ... Global Gimeracil Market Growth 2024-2030 ... analysis in US$ millions of the world Gimeracil industry. This Insight Report ... unique position in an accelerating global Gimeracil market. This Insight Report evaluates ... in the global Gimeracil. United States market for Gimeracil is estimated to increase ... Global Gimeracil Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 ... launches or approvals. Market Segmentation Gimeracil market is split by Type and ... total of 15 chapters: Chapter 1, to describe Gimeracil product scope, market overview, ... and industry chain of Gimeracil. Chapter 14 and 15, to describe Gimeracil sales channel, ... Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 ... 32.2% during review period. Tegafur,Gimeracil and Oteracil Porassium Capsules (S-1 ... approvals. Market Segmentation Tegafur,Gimeracil and Oteracil Porassium Capsules ... chapters: Chapter 1, to describe Tegafur,Gimeracil and Oteracil Porassium Capsules product ... Global Gimeracil Market Research Report 2024(Status and Outlook) ... effects. Positioned as an adjuvant therapy, Gimeracil is a vital component in the ... effective treatment options, where Gimeracil's role as an enhancer of chemotherapy ... present competitive pressures for Gimeracil, necessitating continuous innovation and ... CAS 103766-25-2 Gimeracil Chemical Report & Database ... listed. The substance covered (Gimeracil) are classified by the Chemical ... Report & Database definitions: Name: Gimeracil: Gimeracil; Gimestat; 5-Chloropyridine-2,4-diol Synonyms: ... Chemical or Reaction Intermediate The Gimeracil Report & Database gives Market ... Market Research and Forecast of Antineoplastic Drugs in China 2016-2021 It takes 3-5 business days to dispatch the report after the purchase is made. Antineoplastic drugs develop from traditional single antineoplastic drug towards a new type of antineoplastic drug aiming at functions at multiple links. Research and development ... The Chinese Market for Cancer Intervention The Chinese cancer intervention market reached nearly $41.1 billion in 2016. This market should reach $46.7 billion in 2017 and $89.3 billion by 2022, at a compound annual growth rate (CAGR) of 13.8% through 2022. Cancer treatment services as a segment ... Global Tegafur (Futraful) Market Research Report 2025(Status and Outlook) ... other agents like uracil (UFT) or gimeracil/oteracil (S-1) to enhance efficacy and reduce ... Gastric Cancer Market Assessment, By Type [Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Others], By Stages [Stage I, Stage II, Stage III, Stage IV, Others], By Drug Class [PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others], By Diagnosis [Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Others], By Treatment [Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Others], By Route of Administration [Oral, Parenteral, Others], By Distribution Channel [Hospital Pharmacy, Online Pharmacy, Retail Pharmacy], By End-users [Hospitals, Homecare, ... (recognized as S-1), a composite of three medications—Tegafur, Gimeracil, and Oteracil, in April 2022. Oral ... |